Key statistics
As of last trade Gyre Therapeutics Inc (L9S:DUS) traded at 12.10, -6.92% below its 52-week high of 13.00, set on Sep 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.10 |
---|---|
High | 12.10 |
Low | 12.10 |
Bid | 12.10 |
Offer | 12.30 |
Previous close | 11.90 |
Average volume | 0.00 |
---|---|
Shares outstanding | 93.42m |
Free float | 23.63m |
P/E (TTM) | -- |
Market cap | 1.26bn USD |
EPS (TTM) | -0.8638 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 08:31 BST.
More ▼
Announcements
- Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference
- Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
- Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update
- Gyre Therapeutics to Present at Sidoti Virtual Investor Conference
- Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors
- Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
- Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology
- Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
- Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes
- Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
More ▼